Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy.
AUTHORS
Cooper
WO ,
Cheetham
TC ,
Li
DK ,
Stein
CM ,
Callahan
ST ,
Morgan
TM ,
Shintani
AK ,
Chen
N ,
Griffin
MR ,
Ray
WA ,
. Arthritis & rheumatology (Hoboken, N.J.). 2014 2 ; 66(2). 444-50
- PMID: PMC4077326 [PubMed].
- PMCID: PMC4077326.
- NIHMSID: 101623795
ABSTRACT
To assess the risk of adverse fetal outcomes following exposure to individual immunosuppressive drugs in pregnant women with chronic immune-mediated diseases.
To assess the risk of adverse fetal outcomes following exposure to individual immunosuppressive drugs in pregnant women with chronic immune-mediated diseases.
Tags: Faculty Publications 2014